|
LENZ Lenz Therapeutics Inc 1815776 |
| Balance Sheet |
|
Current Assets
|
$268,367,000.00 |
|
Assets
|
$272,535,000.00 |
|
Current Liabilities
|
$25,806,000.00 |
|
Liabilities
|
$26,043,000.00 |
|
Equity
|
$246,492,000.00 |
|
Shares Out
|
31354394.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-33,582,000.00 |
|
Investing Cash Flow
|
$33,161,000.00 |
| Market Analysis |
Market Cap
|
$180,601,309.44 |
|
Price
|
$5.21 |
|
BVPS
|
7.86 |
|
PB
|
0.73 |
|
EPS
|
-1.32 |
|
PS
|
24.29 |
|
FCF
|
$-33,600,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
|
| Apr |
May |
Jun |
| 2026-03-24 |
-1.16 |
|
|
2026-05-11 |
-1.32 |
|
| Jul |
Aug |
Sep |
|
|
2025-07-30 |
-0.53 |
|
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.59 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LENZ documents filed with the SEC.
LENZ Filings
Clear
